Lakeside Advisors’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-95,280
Closed -$400K 62
2023
Q1
$400K Hold
95,280
0.31% 43
2022
Q4
$573K Hold
95,280
0.47% 34
2022
Q3
$555K Sell
95,280
-2,500
-3% -$14.6K 0.5% 32
2022
Q2
$584K Hold
97,780
0.5% 32
2022
Q1
$457K Hold
97,780
0.34% 36
2021
Q4
$242K Buy
+97,780
New +$242K 0.18% 49